Anecova is a Swiss life science company focused on creating a more natural, physiological approach to Assisted Reproductive Technologies (ART). Our goals are to bring fertility treatment as close as possible to the circumstances of natural conception and to improve the overall quality of fertility care. The first Anecova product, AneVivo, aims to restore the fertilization and early development of the embryo to the natural environment of the maternal womb. This technology enables the embryos to start their life in close communication with the maternal environment.
Looking for a particular Anecova employee's phone or email?
The Anecova annual revenue was $1 million in 2026.
Bryan Tanner is the CEO of Anecova.
4 people are employed at Anecova.
Anecova is based in Lausanne, Vaud.
The NAICS codes for Anecova are [621, 62, 621399, 62139, 6213].
The SIC codes for Anecova are [804, 80].